Significant Heterogeneity in Parameter Assumptions in Cost-Effectiveness Analyses in Prostate Adenocarcinoma: A Systematic Review

被引：1
|
作者：
Butala, A. A. [1 ]
Bryant, C. M. [2 ]
Nichols, R. C., Jr. [2 ]
Henderson, R. H. [2 ]
Hoppe, B. S. [2 ]
Mendenhall, N. P. [2 ]
Vapiwala, N. [1 ]
Vega, R. Mailhot [2 ]
机构：
[1] Univ Penn, Dept Radiat Oncol, Philadelphia, PA 19104 USA
[2] Univ Florida, Coll Med, Dept Radiat Oncol, Gainesville, FL USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2019年 / 105卷 / 01期
关键词：
D O I：
10.1016/j.ijrobp.2019.06.224
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1144
引用
收藏
页码：S181 / S182
页数：2
相关论文
共 50 条
  • [1] Heterogeneity in Radiotherapeutic Parameter Assumptions in Cost-Effectiveness Analyses in Prostate Cancer: A Call for Uniformity
    Butala, Anish A.
    Huang, Christina C.
    Bryant, Curtis M.
    Henderson, Randal H.
    Hoppe, Bradford S.
    Mendenhall, Nancy P.
    Vapiwala, Neha
    Vega, Raymond B. Mailhot
    VALUE IN HEALTH, 2022, 25 (02) : 171 - 177
  • [2] Cost-effectiveness analyses and cost analyses in castration-resistant prostate cancer: A systematic review
    Grochtdreis, Thomas
    Koenig, Hans-Helmut
    Dobruschkin, Alexander
    von Amsberg, Gunhild
    Dams, Judith
    PLOS ONE, 2018, 13 (12):
  • [3] Clarifying Assumptions and Outcomes in Cost-effectiveness Analyses
    ten Haaf, Kevin
    de Koning, Harry J.
    JAMA ONCOLOGY, 2016, 2 (02) : 277 - 278
  • [4] Systematic Review of Cost-Effectiveness Analyses of Treatments for Psoriasis
    Zhang, Wei
    Islam, Nazrul
    Ma, Canice
    Anis, Aslam H.
    PHARMACOECONOMICS, 2015, 33 (04) : 327 - 340
  • [5] A systematic review of cost-effectiveness analyses of pharmacogenomic interventions
    Phillips, KA
    Van Bebber, SL
    PHARMACOGENOMICS, 2004, 5 (08) : 1139 - 1149
  • [6] Cost-effectiveness analyses of denosumab for osteoporosis: a systematic review
    Wan, Y.
    Zeng, F.
    Tan, H.
    Lu, Y.
    Zhang, Y.
    Zhao, L.
    You, R.
    OSTEOPOROSIS INTERNATIONAL, 2022, 33 (05) : 979 - 1015
  • [7] Cost-effectiveness analyses of denosumab for osteoporosis: a systematic review
    Y. Wan
    F. Zeng
    H. Tan
    Y. Lu
    Y. Zhang
    L. Zhao
    R. You
    Osteoporosis International, 2022, 33 : 979 - 1015
  • [8] Systematic Review of Cost-Effectiveness Analyses of Treatments for Psoriasis
    Wei Zhang
    Nazrul Islam
    Canice Ma
    Aslam H. Anis
    PharmacoEconomics, 2015, 33 : 327 - 340
  • [9] Cost-effectiveness Analyses of Antihypertensive Medicines: A Systematic Review
    Park, Chanhyun
    Wang, Guijing
    Durthaler, Jefferey M.
    Fang, Jing
    AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2017, 53 (06) : S131 - S142
  • [10] A systematic review of cost-effectiveness analyses for the treatment of stroke
    Holloway, RG
    Benesch, C
    Courtright, CE
    Rahilly, CR
    ANNALS OF NEUROLOGY, 1998, 44 (03) : 517 - 517
12345